Search

A recent study conducted by the University of Nis in Serbia evaluated the efficacy of ChatGPT, specifically GPT-3.5 and GPT-4, as a tool for solving biostatistical problems in medical education. The study found that while GPT-3.5 was able to solve some practical problems, it struggled with certain types of analyses. On the other hand, GPT-4 was able to provide correct answers for all questions within three attempts. The researchers concluded that students should be cautious when using ChatGPT in medical education, as it can be inaccurate and has limitations. [Extracted from the article]

Most of those changes have been met, and OpenAI now has conditional approval to offer ChatGPT in Italy, with the expectation that it will make further changes specified by the Guarantor, and continue to adhere to EU data privacy rules. ChatGPT is again available to users in Italy, after being temporarily banned by the country's data privacy authority for possible violations of the EU's General Data Protection Regulation (GDPR). [Extracted from the article]